CN101735197B - 一种伊马替尼的合成方法 - Google Patents
一种伊马替尼的合成方法 Download PDFInfo
- Publication number
- CN101735197B CN101735197B CN 200910244893 CN200910244893A CN101735197B CN 101735197 B CN101735197 B CN 101735197B CN 200910244893 CN200910244893 CN 200910244893 CN 200910244893 A CN200910244893 A CN 200910244893A CN 101735197 B CN101735197 B CN 101735197B
- Authority
- CN
- China
- Prior art keywords
- methyl
- benzamide
- phenyl
- pyridine
- methylol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000005517 L01XE01 - Imatinib Substances 0.000 title claims abstract description 32
- 229960002411 imatinib Drugs 0.000 title claims abstract description 32
- KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title abstract description 11
- 230000002194 synthesizing effect Effects 0.000 title abstract 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims abstract description 117
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 29
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 27
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims abstract description 18
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 claims abstract description 12
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims abstract description 10
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims abstract description 9
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical class ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940092714 benzenesulfonic acid Drugs 0.000 claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- 239000003960 organic solvent Substances 0.000 claims description 17
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 16
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 15
- 238000010189 synthetic method Methods 0.000 claims description 15
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 14
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- 230000035484 reaction time Effects 0.000 claims description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 8
- -1 4-chloro-phenyl- Chemical group 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 229960001701 chloroform Drugs 0.000 claims description 6
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 claims description 6
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 238000007259 addition reaction Methods 0.000 abstract 1
- 150000008107 benzenesulfonic acids Chemical class 0.000 abstract 1
- 238000006482 condensation reaction Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 16
- 238000003756 stirring Methods 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- 239000007787 solid Substances 0.000 description 12
- 238000001035 drying Methods 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 238000010792 warming Methods 0.000 description 9
- 238000010992 reflux Methods 0.000 description 8
- CZXGXYBOQYQXQD-UHFFFAOYSA-N methyl benzenesulfonate Chemical compound COS(=O)(=O)C1=CC=CC=C1 CZXGXYBOQYQXQD-UHFFFAOYSA-N 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 238000001816 cooling Methods 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 238000000967 suction filtration Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 229960003685 imatinib mesylate Drugs 0.000 description 4
- YLMAHDNUQAMNNX-UHFFFAOYSA-N imatinib methanesulfonate Chemical compound CS(O)(=O)=O.C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 YLMAHDNUQAMNNX-UHFFFAOYSA-N 0.000 description 4
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- JXRGUPLJCCDGKG-UHFFFAOYSA-N 4-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=C(S(Cl)(=O)=O)C=C1 JXRGUPLJCCDGKG-UHFFFAOYSA-N 0.000 description 3
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000009413 insulation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940095102 methyl benzoate Drugs 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- MGQROXOMFRGAOY-UHFFFAOYSA-N 2-chloro-4-pyridin-3-ylpyrimidine Chemical compound ClC1=NC=CC(C=2C=NC=CC=2)=N1 MGQROXOMFRGAOY-UHFFFAOYSA-N 0.000 description 1
- HIOMYFDDEKSOJQ-UHFFFAOYSA-N 3-bromo-4,4-dimethylcyclohexa-1,5-dien-1-amine Chemical compound CC1(C=CC(=CC1Br)N)C HIOMYFDDEKSOJQ-UHFFFAOYSA-N 0.000 description 1
- BPRVNKJABUKEIG-UHFFFAOYSA-N 4,4-dimethyl-3-nitrocyclohexa-1,5-dien-1-amine Chemical compound C1=CC(C)(C(N(=O)=O)C=C1N)C BPRVNKJABUKEIG-UHFFFAOYSA-N 0.000 description 1
- RCOVTJVRTZGSBP-UHFFFAOYSA-N 4-(chloromethyl)benzoyl chloride Chemical class ClCC1=CC=C(C(Cl)=O)C=C1 RCOVTJVRTZGSBP-UHFFFAOYSA-N 0.000 description 1
- GDIIPKWHAQGCJF-UHFFFAOYSA-N 4-Amino-2-nitrotoluene Chemical compound CC1=CC=C(N)C=C1[N+]([O-])=O GDIIPKWHAQGCJF-UHFFFAOYSA-N 0.000 description 1
- KNBRFZWWCBSGDU-UHFFFAOYSA-N 4-[(4-methylpiperazin-1-yl)methyl]benzoyl chloride Chemical compound C1CN(C)CCN1CC1=CC=C(C(Cl)=O)C=C1 KNBRFZWWCBSGDU-UHFFFAOYSA-N 0.000 description 1
- DSBIJCMXAIKKKI-UHFFFAOYSA-N 5-nitro-o-toluidine Chemical compound CC1=CC=C([N+]([O-])=O)C=C1N DSBIJCMXAIKKKI-UHFFFAOYSA-N 0.000 description 1
- 206010051066 Gastrointestinal stromal tumour Diseases 0.000 description 1
- ABOLPUDOABZSNW-UHFFFAOYSA-N N1CCNCC1.CC1=C(C=C(C(=O)O)C=C1)C(=O)O Chemical compound N1CCNCC1.CC1=C(C=C(C(=O)O)C=C1)C(=O)O ABOLPUDOABZSNW-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- LAZBONZCMJREIQ-UHFFFAOYSA-N ctk7d2096 Chemical compound CC1=CC=C([N+]([O-])=O)C=C1NC(N)=N LAZBONZCMJREIQ-UHFFFAOYSA-N 0.000 description 1
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 description 1
Images
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910244893 CN101735197B (zh) | 2009-12-18 | 2009-12-18 | 一种伊马替尼的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910244893 CN101735197B (zh) | 2009-12-18 | 2009-12-18 | 一种伊马替尼的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101735197A CN101735197A (zh) | 2010-06-16 |
CN101735197B true CN101735197B (zh) | 2013-06-19 |
Family
ID=42459275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200910244893 Active CN101735197B (zh) | 2009-12-18 | 2009-12-18 | 一种伊马替尼的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101735197B (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102250063B (zh) * | 2010-05-19 | 2014-10-22 | 江苏豪森药业股份有限公司 | 甲磺酸伊马替尼的晶型及其制备方法 |
CN102372690B (zh) * | 2010-08-20 | 2014-05-28 | 成都地奥制药集团有限公司 | 用于合成伊马替尼的中间体及其在伊马替尼合成中的应用 |
CN102381988B (zh) * | 2010-08-31 | 2014-05-28 | 凯瑞斯德生化(苏州)有限公司 | 利伐斯的明的中间体化合物的制备方法及中间体化合物 |
CN102382100B (zh) * | 2011-03-09 | 2014-04-16 | 上海昕盛医药科技有限公司 | 伊马替尼的制备方法 |
CN102731474B (zh) * | 2011-04-13 | 2014-12-03 | 石药集团中奇制药技术(石家庄)有限公司 | 一种伊马替尼的制备方法 |
CN102603710A (zh) * | 2011-10-22 | 2012-07-25 | 成都格蓝洋生物医药科技有限公司 | 伊马替尼中间体的制备方法 |
CN102659762A (zh) * | 2012-05-24 | 2012-09-12 | 石药集团中奇制药技术(石家庄)有限公司 | 一种甲磺酸伊马替尼晶型及其制备方法 |
CN104974133B (zh) * | 2014-04-09 | 2018-04-27 | 石药集团中奇制药技术(石家庄)有限公司 | 一种甲磺酸伊马替尼晶型及其制备方法 |
CN105859682A (zh) * | 2015-01-18 | 2016-08-17 | 杨俊� | 一种甲磺酸伊马替尼的合成方法 |
CN109336866A (zh) * | 2018-11-20 | 2019-02-15 | 济南爱思医药科技有限公司 | 一种多取代吡啶环类化合物其制备方法及应用 |
CN111039932B (zh) * | 2019-12-13 | 2023-09-12 | 安徽峆一药业股份有限公司 | 一种拉多替尼的高收率合成方法 |
CN110872279B (zh) * | 2019-12-13 | 2023-09-08 | 安徽峆一药业股份有限公司 | 一种尼洛替尼的高收率合成方法 |
-
2009
- 2009-12-18 CN CN 200910244893 patent/CN101735197B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101735197A (zh) | 2010-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101735197B (zh) | 一种伊马替尼的合成方法 | |
JP5216065B2 (ja) | ピリジルテトラヒドロピリジン類及びピリジルピペリジン類とそれらの製造方法 | |
ES2535166T3 (es) | Pirimidinil-aminas sustituidas como inhibidores de proteína-quinasas | |
CN101386600B (zh) | 具有喹唑二酮骨架的苯丙氨酸衍生物的制造方法及制造中间体 | |
CN105814021B (zh) | 作为激酶抑制剂的取代的烟酰胺衍生物 | |
ES2730086T3 (es) | Compuestos como moduladores de tirosina cinasa | |
CN101454310B (zh) | 11-β-羟类固醇脱氢酶1的抑制剂 | |
ES2344484T3 (es) | Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor gpr38. | |
CN101304978A (zh) | 作为多元抑制剂的喹唑啉衍生物及其制备方法 | |
CN101426783A (zh) | 作为11-β-羟基甾族化合物脱氢酶1的抑制剂的环己基吡唑-内酰胺衍生物 | |
CN106146484A (zh) | 喹唑啉衍生物作为raf激酶调节剂以及它们的方法和用途 | |
TWI376375B (en) | Compounds | |
NO20074324L (no) | Substituerte arylamin sammensetniger og deres andvendelse som 5-HT6 modulatorer | |
CN101203494A (zh) | 合成经取代3-氰基喹啉和其中间物的方法 | |
CN103857672B (zh) | 用于制备1-(4-(4-(3,4-二氯-2-氟苯氨基)-7-甲氧基喹唑啉-6-基氧基)哌啶-1-基)-丙-2-烯-1-酮盐酸盐的方法及其中使用的中间产物 | |
KR920002555A (ko) | 앤지오텐신 ii 수용체 길항질인 신규한 피리미딘 유도체, 그 제조방법 및 그를 포함하는 제약학적 조성물 | |
CN105175284A (zh) | 酰胺类化合物、制备方法及其医药用途 | |
EP1554268A1 (en) | Pyrazole inhibitors of the transforming growth factor | |
JPH02229148A (ja) | 血糖低下活性アミジン化合物およびグアニジン化合物 | |
CN101184748B (zh) | 合成5-(甲基-1h-咪唑-1-基)-3-(三氟甲基)苯胺的方法 | |
ES2375384T3 (es) | Asimadolina para el tratamiento del síndrome de colon irritable (irritable bowel syndroes). | |
CN105658644B (zh) | 取代咪唑用作n型钙通道阻滞剂 | |
CN102234263A (zh) | 一种抗肿瘤药物伊马替尼的制备方法 | |
CN102180867B (zh) | 一种n-{2-[4-(2-嘧啶基)-1-哌嗪]乙基}金刚烷-1-甲酰胺的合成方法 | |
KR100847448B1 (ko) | 3-아릴-5-알킬-1,2,4-옥사다이아졸 유도체, 그 제조방법 및이를 포함하는 비만 예방 또는 치료용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for synthesizing Imatinib Effective date of registration: 20140320 Granted publication date: 20130619 Pledgee: Bank of Tianjin, Limited by Share Ltd, Hongqiao branch Pledgor: Tianjin Weijie Technology Co., Ltd. Registration number: 2014990000178 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20141030 Granted publication date: 20130619 Pledgee: Bank of Tianjin, Limited by Share Ltd, Hongqiao branch Pledgor: Tianjin Weijie Technology Co., Ltd. Registration number: 2014990000178 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for synthesizing Imatinib Effective date of registration: 20141031 Granted publication date: 20130619 Pledgee: Bank of Tianjin, Limited by Share Ltd, Hongqiao branch Pledgor: Tianjin Weijie Technology Co., Ltd. Registration number: 2014990000913 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20151021 Granted publication date: 20130619 Pledgee: Bank of Tianjin, Limited by Share Ltd, Hongqiao branch Pledgor: Tianjin Weijie Technology Co., Ltd. Registration number: 2014990000913 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for synthesizing Imatinib Effective date of registration: 20151021 Granted publication date: 20130619 Pledgee: Bank of Tianjin, Limited by Share Ltd, Tianma subbranch Pledgor: Tianjin Wei Jie Technology Co., Ltd.|Tianjin Wei Czech Pharmaceutical Co., Ltd. Registration number: 2015990000906 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20161017 Granted publication date: 20130619 Pledgee: Bank of Tianjin, Limited by Share Ltd, Tianma subbranch Pledgor: Tianjin Wei Jie Technology Co., Ltd.|Tianjin Wei Czech Pharmaceutical Co., Ltd. Registration number: 2015990000906 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for synthesizing Imatinib Effective date of registration: 20161017 Granted publication date: 20130619 Pledgee: Bank of Tianjin, Limited by Share Ltd, Tianma subbranch Pledgor: Tianjin Wei Jie Technology Co., Ltd.|Tianjin Wei Czech Pharmaceutical Co., Ltd. Registration number: 2016990000880 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20171018 Granted publication date: 20130619 Pledgee: Bank of Tianjin, Limited by Share Ltd, Tianma subbranch Pledgor: Tianjin Weijie Technology Co., Ltd.|Tianjin Weijie Pharmaceutical Co., Ltd. Registration number: 2016990000880 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for synthesizing Imatinib Effective date of registration: 20171018 Granted publication date: 20130619 Pledgee: Bank of Tianjin, Limited by Share Ltd, Tianma subbranch Pledgor: Tianjin Weijie Technology Co., Ltd.|Tianjin Weijie Pharmaceutical Co., Ltd. Registration number: 2017990000966 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20181018 Granted publication date: 20130619 Pledgee: Bank of Tianjin, Limited by Share Ltd, Tianma subbranch Pledgor: Tianjin Weijie Technology Co., Ltd.|Tianjin Weijie Pharmaceutical Co., Ltd. Registration number: 2017990000966 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for synthesizing Imatinib Effective date of registration: 20181018 Granted publication date: 20130619 Pledgee: Bank of Tianjin, Limited by Share Ltd, Tianma subbranch Pledgor: Tianjin Weijie Technology Co., Ltd.|Tianjin Weijie Pharmaceutical Co., Ltd. Registration number: 2018990000977 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PM01 | Change of the registration of the contract for pledge of patent right | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20210930 Registration number: 2018990000977 Pledgee after: Bank of Tianjin Co.,Ltd. second center sub branch Pledgee before: Bank of Tianjin Limited by Share Ltd. Tianma subbranch |